Brent A. Hanks

University of North Carolina at Chapel Hill

Also affiliated with University of North Carolina Health Care, Molecular Oncology (United States), UNC Lineberger Comprehensive Cancer Center

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 17 papers. Top paper: “Three-year survival, correlates and salvage therapies in patients receiving first-line pembrolizumab for advanced Merkel cell carcinoma”.

Three-year survival, correlates and salvage therapies in patients receiving first-line pembrolizumab for advanced Merkel cell carcinoma

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-002478

N/A

4.0DataRank · unranked

140 citations

Shailender Bhatia, Evan J. Lipson, William H. Sharfman, Ragini R. Kudchadkar, Andrew S. Brohl +24 more

Dissecting the immune landscape of tumor draining lymph nodes in melanoma with high-plex spatially resolved protein detection

Cancer Immunology Immunotherapy(2020)10.1007/s00262-020-02698-2

N/A

0DataRank · unranked

8 citations

Aaron D Therien, Eda K. Holl, Rami N. Al‐Rohil, Maria Angelica Selim, Nellie E. Farrow +7 more

Role of dendritic cell metabolic reprogramming in tumor immune evasion

International Immunology(2020)10.1093/intimm/dxaa036

N/A

0DataRank · unranked

32 citations

Michael Sturdivant, Nicholas C. DeVito, Brent A. Hanks, Michael P. Plebanek

The State of Melanoma: Emergent Challenges and Opportunities

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-4092

N/A

0DataRank · unranked

108 citations

Clara Curiel‐Lewandrowski, David E. Fisher, Susan M. Swetter, Hensin Tsao, Julio A. Aguirre‐Ghiso +31 more

Pharmacological Wnt ligand inhibition overcomes key tumor-mediated resistance pathways to anti-PD-1 immunotherapy

Cell Reports(2021)10.1016/j.celrep.2021.109071

N/A

0DataRank · unranked

82 citations

Michael Sturdivant, Balamayooran Thievanthiran, Christine Xiao, Michael P. Plebanek, April K.S. Salama +6 more

APOBEC Mutagenesis Inhibits Breast Cancer Growth through Induction of T cell–Mediated Antitumor Immune Responses

Cancer Immunology Research(2021)10.1158/2326-6066.cir-21-0146

N/A

0DataRank · unranked

65 citations

Xiaodi Qin, Brock J. McKinney, Nina Marie G. Garcia, Sarah C. Van Alsten, Elizabeth A. Mendes +7 more

Overcoming Immunotherapy Resistance by Targeting the Tumor-Intrinsic NLRP3-HSP70 Signaling Axis

Cancers(2021)10.3390/cancers13194753

N/A

0DataRank · unranked

18 citations

Tarek Haykal, Linda Cao, Alisha Holtzhausen, Michael P. Plebanek, Nicholas C. DeVito +2 more

Clinical Trials with Biologic Primary Endpoints in Immuno-oncology: Concepts and Usage

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-1593

N/A

0DataRank · unranked

6 citations

Aaron C. Tan, Brent A. Hanks, Xiaofei Wang, Kouros Owzar, James E. Herndon +4 more

APOBEC mutagenesis inhibits breast cancer growth through induction of a T cell-mediated antitumor immune response

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.02.13.431068

N/A

0DataRank · unranked

1 citations

Xiaodi Qin, Sarah Van Alsten, Brock J. McKinney, Nina Marie G. Garcia, Jeremy Force +6 more

Tumor-intrinsic NLRP3-HSP70-TLR4 axis drives premetastatic niche development and hyperprogression during anti–PD-1 immunotherapy

Science Translational Medicine(2022)10.1126/scitranslmed.abq7019

N/A

0DataRank · unranked

55 citations

Nagendra Yarla, Tarek Haykal, Y‐Van Nguyen, Linda Cao, Michelle Ferreira +8 more

Management of Microsatellite Instability High (MSI-H) Gastroesophageal Adenocarcinoma

Journal of Gastrointestinal Cancer(2023)10.1007/s12029-023-01003-5

N/A

0DataRank · unranked

8 citations

Brent A. Hanks, John H. Strickler, Katherine I. Zhou

A SREBF2-dependent gene program drives an immunotolerant dendritic cell population during cancer progression

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.04.26.538456

N/A

0DataRank · unranked

3 citations

Yue Xue, Y‐Van Nguyen, Nicholas C. DeVito, Xueying Wang, Alisha Holtzhausen +5 more

A lactate-SREBP2 signaling axis drives tolerogenic dendritic cell maturation and promotes cancer progression

Science Immunology(2024)10.1126/sciimmunol.adi4191

N/A

0DataRank · unranked

126 citations

Yue Xue, Y‐Van Nguyen, Nicholas C. DeVito, X F Wang, Alisha Holtzhausen +4 more

Gli2 Facilitates Tumor Immune Evasion and Immunotherapeutic Resistance by Coordinating Wnt Ligand and Prostaglandin Signaling

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.03.31.587500

N/A

0DataRank · unranked

1 citations

Y‐Van Nguyen, Michael Sturdivant, Michael P. Plebanek, Kaylee Howell, Nagendra Yarla +6 more

APOBEC Mutagenesis Inhibits Breast Cancer Growth through Induction of T cell-Mediated Antitumor Immune Responses

UNC Libraries(2024)10.17615/jb7q-g362

N/A

0DataRank · unranked

0 citations

Melissa A. Troester, Xianhui Qin, Nina Marie G. Garcia, Jingjing Xie, Jeremy Force +7 more

A tumor-intrinsic PD-L1/NLRP3 inflammasome signaling pathway drives resistance to anti–PD-1 immunotherapy

Journal of Clinical Investigation(2020)10.1172/jci133055

N/A

0DataRank · unranked

251 citations

Kathy S. Evans, Nicholas C. DeVito, Michael P. Plebanek, Michael Sturdivant, Luke P. Wachsmuth +10 more

Tumor NLRP3 Amplification Promotes Immunotherapy Resistance by Suppressing MHC Class I Expression

medRxiv(2025)10.1101/2025.10.06.25337175

N/A

0DataRank · unranked

0 citations

Nagendra Sastry Yarla, Kaylee Villareal, Y‐Van Nguyen, Linda Cao, Ernesto Pena Calderin +9 more